SCHEMBL6755045

SCHEMBL6755045

CCCCCCCCCCCCCCCCC(C(=O)O)C(OCC)(C(=O)O)C(CC)(CC)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPD1 P10809 1/20 0.48
BLM P54132 1/20 0.48
HSPE1 P61604 1/20 0.48
MEN1 O00255 1/20 0.47
HPGD P15428 1/20 0.47
RECQL P46063 1/20 0.47
KMT2A Q03164 1/20 0.47
HSD17B10 Q99714 1/20 0.47
LCK P06239 1/20 0.42
PPARD Q03181 1/20 0.42
ZDHHC20 Q5W0Z9 1/20 0.42
ZDHHC2 Q9UIJ5 1/20 0.42
GPR84 Q9NQS5 7/20 0.40
FFAR1 O14842 2/20 0.40
MAPT P10636 1/20 0.39
ACE2 Q9BYF1 1/20 0.37
GRIK1 P39086 2/20 0.35
GRIK2 Q13002 2/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL690431 0.83 HSPD1 (0.37) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL8746528 0.81 HSPD1 (0.46) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL820028 0.81 HSPD1 (0.46) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL375645 0.81 HSPD1 (0.46) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL6663512 0.78 HSPD1 (0.37) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL285119 0.78 HSPD1 (0.43) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL8747679 0.78 CES2 (0.38) MEN1KMT2AHSD17B10PPARDGPR84
SCHEMBL9836187 0.77 FOLH1 (0.31)
SCHEMBL8747497 0.76 CES2 (0.36) MEN1KMT2AHSD17B10PPARDGPR84
SCHEMBL17995738 0.75 HSPD1 (0.40) HSPD1BLMHSPE1MEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9107804-B2 Method of preparing biologically active formulations NORTEC DEVELOPMENT ASSOCIATES, INC. (US) 2015-08-18 US disclosed
US-20040185111-A1 pellet for use as a core for a dosage form, having an inner zone that includes the drug and an outer zone which includes a layer formed by applying a substantially dry, free flowing inert powder which forms a non-tacky surface in water; made with use of a rotating device NORTEC DEVELOPMENT ASSOCIATES, INC. 2004-09-23 US disclosed